Article Correctness Is Author's Responsibility: 2 catheters originally developed by Dr. Riyaz Bashir receive premarket clearance by FDA

(Temple University Health System) The US Food and Drug Administration has granted premarket notification clearance for two catheters invented by Riyaz Bashir, MD, FACC, RVT, Director of Vascular and Endovascular Medicine at Temple University Hospital, and Nicholas Green, Director of Research & Development at Thrombolex, Inc. Thrombolex is a company founded in partnership with Temple University to develop these catheter-based clot dissolving devices. This clearance now allows Thrombolex to commercialize the catheters.